How long can you live if breast cancer metastasizes to the liver?

After breast cancer spreads to the lymph nodes, timely surgery and postoperative adjuvant radiotherapy, chemotherapy and other treatments can prolong the patient's survival time. For stage IV breast cancer, according to current clinical treatment statistics, its 5-year survival rate or cure rate is generally less than 10%, which means that the probability of cure for stage 4 breast cancer is not high. The survival time of breast cancer cells after spread is related to whether the cancer cells are locally metastatic or distantly metastatic throughout the body, and cannot be generalized.

Breast cancer patients should not eat four things

Breast cancer patients cannot eat pickled, smoked, fried, or grilled foods. These foods are not only difficult to digest, but also have some factors that are not conducive to the body's recovery during the high-temperature heating process or the long-term smoking and pickling process. They are metabolized in the body, which is not conducive to the recovery of the disease. Breast cancer patients cannot eat spicy and other irritating foods during the course of the disease, such as garlic, peppers, etc. Breast cancer patients cannot eat foods such as grilled and fried foods, seafood and river foods, warm foods, spicy foods, and pickled foods.

What is the survival rate for HER2-positive breast cancer?

Human epidermal growth factor receptor-2 HER-2 positive breast cancer accounts for 15% to 20% of all breast cancer molecular types. This type of breast cancer is highly malignant and has a poor prognosis. Compared with other types, the survival of HER-2 positive breast cancer is not very good and requires active treatment, such as molecular targeted Herceptin treatment and evaluation to see if there is metastasis. In recent years, targeted therapeutic drugs targeting the HER2 molecule in breast cancer have been approved for marketing, such as trastuzumab, lapatinib, pertuzumab, T-DM1, etc., which have significantly prolonged the survival of patients with HER2 positive breast cancer.